GAD2 and autoimmune pancreatitis: In this study, pancreatic autoimmunity was observed in 30.71% of patients, a relatively low rate compared with that observed in other countries (56.60–90.00%).[19,25,26] A low prevalence of anti-GAD-65 and IAAs was observed, at 5% and 3%, respectively.